Company
United StatesPublic company, NASDAQ: NGNENEUROGENE INC (NASDAQ: NGNE), New York, NY – FDA Inspections
Inspection records and compliance data for NEUROGENE INC in New York, New York. 1 FDA inspection on record, last inspected July 11, 2025. Publicly traded as NASDAQ: NGNE.
Company Profile
This profile covers NEUROGENE INC based in New York, New York, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected July 11, 2025.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 11, 2025 | Not classified | Biologics | 1276861 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Westchester Medical Center
Stratton VA Medical Center Transfusion Service (113c)
Rochester Eye & Human Parts Bank, Inc.
Cayuga Medical Center at Ithaca, Inc.
New York Downtown Hospital
Dr. Donna Futterman
Wyckoff Heights Medical Center Blood Bank
Philip L. McCarthy, M.D.
Saratoga Hospital Laboratory
Montefiore Medical Center - Wakefield Hospital
Company Information
Name
NEUROGENE INC
Stock ticker
NGNE
Exchange
NASDAQ
Share price
$25.79
Market cap
$516.1M
Price as of
November 6, 2026
FEI Number
3022279827
Address
New York, New York 10011, United States
Country
United States
ID: e1f5ef5c-6404-43a7-9128-4e7bb87abede